TY - JOUR
AU - Joshua, Anthony
AU - Ardolino, Luke
TI - Immune checkpoint inhibitors in malignancy
J2 - Aust Prescr
JF - Australian Prescriber
PY - 2019
ET - 2019/04/01
VL - 42
IS - 2
SP - 62
EP - 67
DO - 10.18773/austprescr.2019.012
LA - eng
UR - https://australianprescriber.tg.org.au/articles/immune-checkpoint-inhibitors-in-malignancy.html
KW - avelumab
KW - durvalumab
KW - Ipilimumab
KW - melanoma
KW - nivolumab
KW - non-small cell lung cancer
KW - pembrolizumab
KW - bladder cancer
PB - Therapeutic Guidelines Ltd
SN - 1839-3942
ER -